Indiana University (IU) — Indianapolis, Indiana

Indiana University (IU) is a clinical research site located in Indianapolis, Indiana, United States 46202.

Crixeo Clinical Trials Trust Score: 71/100 (FAIR). This profile has not yet been claimed by the site owner.

Indiana University (IU) has participated in 5 clinical trials with 3 currently active.

Therapeutic areas: Platinum-resistant Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer.

Sponsors: Mural Oncology, Inc, NeuMoDx Molecular, Inc., Eli Lilly and Company.

Sponsor Feasibility Report

Trust Score: 71/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Indiana University (IU)?

Indiana University (IU) has a Crixeo Trust Score of 71/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Indiana University (IU) conducted?

Indiana University (IU) has 5 clinical trials on record, with 3 currently active. Their work covers Platinum-resistant Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer.

Is Indiana University (IU) accredited by Crixeo Clinical Trials?

Indiana University (IU) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Indiana University (IU)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.